$71.25
0.25% yesterday
Nasdaq, Nov 17, 10:00 pm CET
ISIN
US8064071025
Symbol
HSIC

Henry Schein Stock price

$71.25
+8.27 13.13% 1M
-0.59 0.82% 6M
+2.05 2.96% YTD
-2.64 3.57% 1Y
-7.95 10.04% 3Y
+6.64 10.28% 5Y
+10.82 17.90% 10Y
+54.28 319.91% 20Y
Nasdaq, Closing price Mon, Nov 17 2025
-0.18 0.25%

New AI Insights on Henry Schein Insights AI Insights on Henry Schein

How does the company make money?
Who are the company’s main competitors?

Key metrics

Basic
Market capitalization
$8.4b
Enterprise Value
$11.4b
Net debt
$3.0b
Cash
$136.0m
Shares outstanding
118.6m
Valuation (TTM | estimate)
P/E
22.1 | 14.5
P/S
0.7 | 0.6
EV/Sales
0.9 | 0.9
EV/FCF
31.9
P/B
2.5
Financial Health
Equity Ratio
33.2%
Return on Equity
11.5%
ROCE
9.7%
ROIC
6.1%
Debt/Equity
0.9
Financials (TTM | estimate)
Revenue
$12.9b | $13.3b
EBITDA
$1.0b | $1.1b
EBIT
$769.0m | $978.7m
Net Income
$391.0m | $583.2m
Free Cash Flow
$356.0m
Growth (TTM | estimate)
Revenue
3.5% | 4.6%
EBITDA
20.1% | 9.6%
EBIT
26.5% | 32.8%
Net Income
24.5% | 49.5%
Free Cash Flow
-9.0%
Margin (TTM | estimate)
Gross
31.2%
EBITDA
7.9% | 8.4%
EBIT
5.9%
Net
3.0% | 4.4%
Free Cash Flow
2.8%
More
EPS
$3.2
FCF per Share
$3.0
Short interest
8.2%
Employees
25k
Rev per Employee
$510.0k
Show more

Is Henry Schein a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,042 stocks worldwide.

Henry Schein Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a Henry Schein forecast:

10x Buy
43%
11x Hold
48%
2x Sell
9%

Analyst Opinions

23 Analysts have issued a Henry Schein forecast:

Buy
43%
Hold
48%
Sell
9%

Financial data from Henry Schein

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
12,938 12,938
4% 4%
100%
- Direct Costs 8,903 8,903
4% 4%
69%
4,035 4,035
2% 2%
31%
- Selling and Administrative Expenses 3,009 3,009
3% 3%
23%
- Research and Development Expense - -
-
-
1,026 1,026
20% 20%
8%
- Depreciation and Amortization 257 257
4% 4%
2%
EBIT (Operating Income) EBIT 769 769
26% 26%
6%
Net Profit 391 391
25% 25%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Henry Schein directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Henry Schein Stock News

Neutral
Investopedia
4 days ago
If you're looking to diversify your stock portfolio away from AI, Bank of America has some suggestions.
Neutral
Business Wire
5 days ago
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., (Nasdaq: HSIC) the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conference in December: Piper Sandler's Healthcare Conference at the Lotte New York Palace Hotel, New York, on December 2, 2025, at 9:00 a.m. Eastern tim...
Neutral
Seeking Alpha
5 days ago
Henry Schein, Inc. ( HSIC ) Stifel 2025 Healthcare Conference November 12, 2025 11:20 AM EST Company Participants Andrea Albertini - Chief Executive Officer of Global Distribution & Technology Tom Popeck - Chief Executive Officer of Henry Schein Products Group Ronald South - Senior VP & CFO Conference Call Participants Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division...
More Henry Schein News

Company Profile

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial services on a non-recourse basis, e-services practice, technology, network and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Head office United States
CEO Stanley Bergman
Employees 25,000
Founded 1932
Website www.henryschein.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today